Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Due to Alzheimer's Disease (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04049643
What this trial is testing

Hearing Aid and Individuals With Cognitive Disorders

Who this might be right for
Presbycusis, BilateralAlzheimer Disease 2 Due to Apoe4 IsoformMild Cognitive Impairment
Yu-Hsiang Wu 17
Early research (Phase 1)Study completedNCT01600859
What this trial is testing

Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)

Who this might be right for
Alzheimer's Disease
Eisai Inc. 65
Testing effectiveness (Phase 2)Study completedNCT03061474
What this trial is testing

Nicotinamide as an Early Alzheimer's Disease Treatment

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
University of California, Irvine 46
Testing effectiveness (Phase 2)Study completedNCT02702817
What this trial is testing

Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseCognitive Decline Due to Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer Disease
Douglas Mental Health University Institute 200
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Testing effectiveness (Phase 2)Study completedNCT04971733
What this trial is testing

Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eisai Inc. 8
Testing effectiveness (Phase 2)Looking for participantsNCT06781333
What this trial is testing

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

Who this might be right for
Alzheimer DiseaseAgitation in Dementia
Bernard (Barry) Baumel 8
Early research (Phase 1)Study completedNCT06546995
What this trial is testing

Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseHealthy Elderly
Neumora Therapeutics, Inc. 87
Post-approval studies (Phase 4)WithdrawnNCT01822951
What this trial is testing

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

Who this might be right for
Alzheimer Disease
Ever Neuro Pharma GmbH
Testing effectiveness (Phase 2)Ended earlyNCT04795466
What this trial is testing

Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Novartis Pharmaceuticals 34
Not applicableActive Not RecruitingNCT02951598
What this trial is testing

Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Eli Lilly and Company 1,400
Testing effectiveness (Phase 2)Study completedNCT05619692
What this trial is testing

Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive ImpairmentMild DementiaAlzheimer's Disease
Supernus Pharmaceuticals, Inc. 174
Early research (Phase 1)Ended earlyNCT02573740
What this trial is testing

Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
AbbVie 8
Not applicableLooking for participantsNCT07768579
What this trial is testing

The Effect of Sequential Therapy on Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer DiseaseAlzheimer Disease
Dongzhimen Hospital, Beijing 600
Testing effectiveness (Phase 2)Study completedNCT02788513
What this trial is testing

BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 611
Testing effectiveness (Phase 2)Ended earlyNCT03639987
What this trial is testing

Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities

Who this might be right for
Cognitive DysfunctionAlzheimer's Disease
Biogen 52
Large-scale testing (Phase 3)Looking for participantsNCT07169578
What this trial is testing

Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Testing effectiveness (Phase 2)Looking for participantsNCT06489548
What this trial is testing

Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

Who this might be right for
DementiaAlzheimers DiseaseMild Cognitive Impairment Due to Alzheimer's Disease
Brigham and Women's Hospital 16
Large-scale testing (Phase 3)Ended earlyNCT01953601
What this trial is testing

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 1,454
Testing effectiveness (Phase 2)Study completedNCT03462121
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

Who this might be right for
Mild to Moderate Dementia Due to Alzheimer's DiseaseWith or Without Coexisting Cerebrovascular Disease
Regenera Pharma Ltd 83
Next Page